EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases

Thibault Kervarrec iD, Danna Westphal, Daniel Pissaloux iD, Mélanie Legrand iD, Franck Tirode, Anne Neuhart, Francoise Drouot, Jürgen C Becker, Nicolas Macagno, Alice Seris, Thomas Jouary, Fanny Beltzung und 11 weitere

Histopathology · 2024

DOI: 10.1111/his.15214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Thibault Kervarrec und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France. Hauptthemen laut MEDLINE: Eccrine Porocarcinoma, p21-Activated Kinases, Sweat Gland Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Société Française de Dermatologie et de Pathologie Sexuellement Transmissible.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Porocarcinoma is a malignant sweat gland tumour differentiated toward the upper part of the sweat duct and may arise from the transformation of a preexisting benign poroma. In 2019, Sekine et al. demonstrated the presence of YAP1::MAML2 and YAP1::NUTM1 fusions in most poromas and porocarcinomas. Recently, our group identified PAK2‐ fusions in a subset of benign poromas. Herein we report a series of 12 porocarcinoma cases harbouring PAK1/2/3 fusions. Methods and Results Five patients were male and the median age was 79 years (ranges: 59–95). Tumours were located on the trunk ( n = 7), on the thigh ( n = 3), neck ( n = 1), or groin area ( n = 1). Four patients developed distant metastases. Microscopically, seven cases harboured a benign poroma component and a malignant invasive part. Ductal formations were observed in all, while infundibular/horn cysts and cells with vacuolated cytoplasm were detected in seven and six tumours, respectively. In three cases, the invasive component consisted of a proliferation of elongated cells, some of which formed pseudovascular spaces, whereas the others harboured a predominant solid or trabecular growth pattern. Immunohistochemical staining for CEA and EMA confirmed the presence of ducts. Focal androgen receptor expression was detected in three specimens. Whole RNA sequencing evidenced LAMTOR1::PAK1 ( n = 2), ZDHHC5::PAK1 ( n = 2), DLG1::PAK2 , CTDSP1::PAK1 , CTNND1::PAK1 , SSR1::PAK3 , CTNNA1::PAK2 , RNF13::PAK2 , ROBO1::PAK2, and CD47::PAK2 . Activating mutation of HRAS (G13V, n = 3, G13R, n = 1, Q61L, n = 2) was present in six cases.

Conclusion

Our study suggests that PAK1/2/3 fusions is the oncogenic driver of a subset of porocarcinomas lacking YAP1 rearrangement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eccrine Porocarcinomap21-Activated KinasesSweat Gland NeoplasmsAgedAged, 80 and overFemaleHumansMaleMiddle AgedOncogene Proteins, Fusion

Substanzen

Oncogene Proteins, Fusionp21-Activated KinasesPAK1 protein, humanPAK2 protein, humanPAK3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France.
  • "Biologie des infections à polyomavirus" Team, UMR INRA ISP 1282, Université de Tours, Tours, France.
  • CARADERM Network.
  • National Center for Tumour Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Department of Biopathology, Center Léon Bérard, Lyon, France.

ORCID-Profile: Thibault Kervarrec, Daniel Pissaloux, Mélanie Legrand, Paul W Harms, Gaelle Fromont

Förderung

  • Société Française de Dermatologie et de Pathologie Sexuellement Transmissible

Zitieren

APA

Kervarrec, T., Westphal, D., Pissaloux, D., Legrand, M., Tirode, F., Neuhart, A., Drouot, F., Becker, J. C., Macagno, N., Seris, A., Jouary, T., Beltzung, F., Jullie, M. L., Harms, P. W., Cribier, B., Mourah, S., Jouenne, F., Fromont, G., Louveau, B., …, & Battistella, M. (2024). Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases. Histopathology. https://doi.org/10.1111/his.15214

Vancouver

Kervarrec T, Westphal D, Pissaloux D, Legrand M, Tirode F, Neuhart A, et al. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases. Histopathology. 2024. doi:10.1111/his.15214

BibTeX
@article{Kervarrec2024,
  author = {Kervarrec, Thibault and Westphal, Danna and Pissaloux, Daniel and Legrand, Mélanie and Tirode, Franck and Neuhart, Anne and Drouot, Francoise and Becker, Jürgen C and Macagno, Nicolas and Seris, Alice and Jouary, Thomas and Beltzung, Fanny and Jullie, Marie-Laure and Harms, Paul W and Cribier, Bernard and Mourah, Samia and Jouenne, Fanélie and Fromont, Gaelle and Louveau, Baptiste and Mancini, Maxence and Kazakov, Dmitry V and de la Fouchardière, Arnaud and Battistella, Maxime},
  title = {Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15214}
}
Kostenlos starten →